Back to top
more

Bruker (BRKR)

(Delayed Data from NSDQ)

$30.66 USD

30.66
5,943,060

-1.41 (-4.40%)

Updated Aug 6, 2025 04:00 PM ET

After-Market: $30.64 -0.02 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (234 out of 246)

Industry: Instruments - Scientific

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Luminex xMAP Picked by EDP Biotech to Boost Cancer Diagnostics

by Zacks Equity Research

Management at Luminex (LMNX) expects to see robust demand for Luminex's xMAP technology in 2019.

Zacks Equity Research

Here's Why You Should Retain Bio-Rad (BIO) Stock For Now

by Zacks Equity Research

Bio-Rad (BIO) continues to witness high investor confidence on strength in the Life Sciences segment.

Zacks Equity Research

Medtronic Receives FDA Nod for SelectSite Catheter System

by Zacks Equity Research

The launch of the SelectSite catheter is in line with Medtronic's (MDT) goal to expand its cardiac care portfolio.

Zacks Equity Research

Masimo's Technologies to be Deployed to Boost Pediatric Care

by Zacks Equity Research

NuVision's centers are to be equipped with Masimo's (MASI) SET, Root with Radical-7, NomoLine Capnography and Patient SafetyNet technologies.

Zacks Equity Research

Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

by Zacks Equity Research

IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.

Zacks Equity Research

QIAGEN (QGEN) Launches PIK3CA Kit for Breast Cancer Patients

by Zacks Equity Research

QIAGEN's (QGEN) therascreen PIK3CA Kit is the first companion diagnostic test to have attained premarket approval from the FDA.

Zacks Equity Research

Here's Why You Should Retain NuVasive (NUVA) Stock for Now

by Zacks Equity Research

Investor confidence in the stock is high on NuVasive's (NUVA) sturdy spine business.

Zacks Equity Research

Here's Why You Should Hold on to Hill-Rom (HRC) Stock Now

by Zacks Equity Research

Investor confidence in the stock is high on Hill-Rom's (HRC) recent acquisition of Voalte.

Zacks Equity Research

Here's Why You Should Hold Varian Medical (VAR) Stock Now

by Zacks Equity Research

Varian Medical (VAR) raises revenue guidance for 2019 encourages.

Zacks Equity Research

Bruker (BRKR) Q1 Earnings Beat Estimates, Guidance Upbeat

by Zacks Equity Research

Bruker's (BRKR) current focus on product development through higher R&D investment stokes investors' positive sentiment around the stock.

Zacks Equity Research

Here's Why Momentum Investors Will Love Bruker (BRKR)

by Zacks Equity Research

Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Bruker (BRKR) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Bruker (BRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why Bruker (BRKR) is a Solid Choice

by Zacks Equity Research

Bruker (BRKR) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Bruker (BRKR) delivered earnings and revenue surprises of 16.67% and 1.45%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Bruker (BRKR) Reports Next Week: What to Know Ahead of the Release

by Zacks Equity Research

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aniruddha Ganguly headshot

Scientific Instruments Industry Outlook: Prospects Look Bright

by Aniruddha Ganguly

The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for April 11th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 11th.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for April 10th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 10th.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for April 8th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 8th.

Zacks Equity Research

Are You Looking for a Top Momentum Pick? Why Bruker (BRKR) is a Great Choice

by Zacks Equity Research

Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for March 29th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 29th.

Zacks Equity Research

Is Bruker (BRKR) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Bruker (BRKR) could produce exceptional returns because of its solid growth attributes.

Zacks Equity Research

Bruker Consistently Gains From NANO & New Strategic Buyouts

by Zacks Equity Research

Bruker (BRKR) is progressing well with its three strategic buyouts, indicative of a majority interest in both Hain Diagnostics and Mestrelab along with the Alicona Imaging acquisition.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for March 27th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 27th.

Zacks Equity Research

Top Ranked Growth Stocks to Buy for March 26th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, March 26th.